The Europe malaria treatment market was valued at US$ 451.69 million in 2022 and is expected to reach US$ 3,060.97 million by 2030; it is estimated to grow at a CAGR of 27.0% from 2022 to 2030.
Antimicrobial resistance can put the public at risk of many diseases, such as malaria. To overcome this challenge, the R&D of new medicines is considered the best strategy; as a result, the antimalarial pipeline is becoming increasingly robust. Public-private partnerships are accelerating research activities related to the treatment of malaria. For instance, Medicines for Malaria Venture (MMV), a nonprofit organization, works with numerous pharmaceutical companies to reduce the burden of malaria by developing novel treatment options.
A few antimalarial that are under clinical development are mentioned in the table below:
Drug | Developer | Clinical Trial Stage |
Artefenomel | Sanofi | Phase IIb |
KAE609 | Novartis AG | Phase IIb |
KAF156 | Novartis AG | Phase IIb |
DSM265 | Takeda Pharmaceutical Company | Phase IIa |
SANARIA PfSPZ-GA1 | Sanaria | Phase II |
SANARIA PfSPZ Vaccine – Radiation Attenuated PfSPZ Vaccine | Sanaria | Phase II |
SANARIA PfSPZ-CVac | Sanaria | Phase II |
MSP3-CRM-Vac4All | Vac4All | Phase I |
Liver-Stage Antigen-3 (LSA3) | Vac4All | Phase IIa |
Source: Company Website, The Insight Partners Analysis
Therefore, the growing number of antimalarial and drugs/vaccines that are under clinical development are expected to boost the market growth in the future.
According to a surveillance report by ECDC, France reported the highest number of malaria cases in 2020. In 2020, France reported 1,007 confirmed malaria cases. Nearly all the cases reported by EU/EEA countries in 2020 were diagnosed in people traveling to France from other countries; these mostly included individuals linked to travel routes from West Africa. In France, P. falciparum is responsible for almost all severe cases and deaths in travelers. Many research organizations are working toward developing new approaches to eliminate malaria in France. For example, teams at the Institut Pasteur are dedicated to malaria research aiming to develop vaccines. This research is vital in finding new ways of fighting malaria. The Institute Pasteur is also taking part in a major European program named EVIMalaR, which involves 17 research institutes and universities from 7 European countries, and partners from 3 African countries. Such collaborative efforts toward malaria elimination are driving the growth of the malaria treatment market in France.
Strategic insights for the Europe Malaria Treatment provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.
Report Attribute | Details |
---|---|
Market size in 2022 | US$ 451.69 Million |
Market Size by 2030 | US$ 3,060.97 Million |
Global CAGR (2022 - 2030) | 27.0% |
Historical Data | 2020-2021 |
Forecast period | 2023-2030 |
Segments Covered |
By Treatment
|
Regions and Countries Covered | Europe
|
Market leaders and key company profiles |
The geographic scope of the Europe Malaria Treatment refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.
The Europe malaria treatment market is segmented based on treatment, route of administration, distribution channel, and country. Based on treatment, the Europe malaria treatment market is segmented into generic drugs, originators, vaccines, and others. The generic drugs segment held the largest market share in 2022.
In terms of route of administration, the Europe malaria treatment market is bifurcated into oral and parenteral. The oral segment held a larger market share in 2022.
By distribution channel, the Europe malaria treatment market is segmented into direct tender, hospital pharmacies, retail pharmacies, online pharmacies, and others. The direct tender segment held the largest market share in 2022.
Based on country, the Europe malaria treatment market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. France dominated the Europe malaria treatment market share in 2022.
Cipla Ltd, Sun Pharmaceutical Industries Ltd, Sanofi SA, GSK Plc, Novartis AG, Pfizer Inc, and Lupin Ltd are some of the leading players operating in the Europe malaria treatment market.
1. Cipla Ltd
2. Sun Pharmaceutical Industries Ltd
3. Sanofi SA
4. GSK Plc
5. Novartis AG
6. Pfizer Inc
7. Lupin Ltd
The Europe Malaria Treatment Market is valued at US$ 451.69 Million in 2022, it is projected to reach US$ 3,060.97 Million by 2030.
As per our report Europe Malaria Treatment Market, the market size is valued at US$ 451.69 Million in 2022, projecting it to reach US$ 3,060.97 Million by 2030. This translates to a CAGR of approximately 27.0% during the forecast period.
The Europe Malaria Treatment Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Malaria Treatment Market report:
The Europe Malaria Treatment Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Malaria Treatment Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Malaria Treatment Market value chain can benefit from the information contained in a comprehensive market report.